Australia’s vaccine safety and regulatory process is world class and people can be confident that vaccines approved for use are safe and effective. Our vaccines will save lives and are an essential part of tackling this global pandemic.
Australia is taking a phased approach to the vaccination program roll out. Australia is currently utilising two vaccines – the Pfizer and the AstraZeneca vaccines.
Our clear focus during the vaccine rollout remains the safety of all Australians. As throughout the whole of the COVID-19 pandemic, we have relied upon our medical experts for advice and guidance to ensure a safe and effective program delivery.
A small number of people, predominantly overseas (in the United Kingdom and Europe) have presented with clotting disorders following vaccination with the AstraZeneca vaccine.
One case has been reported in Australia today and is being investigated by the Therapeutic Goods Administration (TGA).
Medical experts within the European Medicines Agency and the UK Healthcare Products Regulatory Agency have not confirmed a causal link with the AstraZeneca COVID-19 vaccine but continue to look in great detail at the available data and clinical circumstances around these reports.
Similarly, our expert committees, the Australian Technical Advisory Group on Immunisation (ATAGI) and the National Vaccine Safety Investigation Group (VSIG), in conjunction with our independent regulator, the TGA are monitoring the situation closely, both in Australia and internationally.